XML 27 R16.htm IDEA: XBRL DOCUMENT
v3.26.1

WARRANT LIABILITY | 3 Months Ended
--- | ---
Mar. 31, 2026
Warrant Liability |
WARRANT LIABILITY | NOTE 8– WARRANT LIABILITY The May 2025 Warrants (see Note 3) do not meet all the equity classification criteria and therefore were determined to be classified as liabilities measured at fair value through earnings. The Company utilized the Black Scholes Model to calculate the value of the May 2025 Warrants. The aggregate fair value of the May 2025 Warrants as of March 31, 2026, was $824 and was estimated using the Black Scholes Model and using the following assumptions: stock price $2.38, exercise price $20.40, dividend yield 0%; remaining term of 4.13 years; equity volatility of 152.31%; and a risk-free interest rate of 3.92%. ENVUE MEDICAL, INC. Notes to the Interim Condensed Consolidated Financial Statements (unaudited) (Amounts in thousands except share and per share data) The Company recognized changes in the fair value of the warrant liability of $17 during the three months ended March 31, 2026, as financial income on the consolidated statement of operations. Changes in the warrant liability balance Below is the change in the warrant liability balance for the three months ended March 31, 2026: SCHEDULE OF CHANGE IN WARRANT LIABILITY
Balance as of December 31, 2025 |  | $ | 807 |
Change in fair value |  |  | 17 |
Balance as of March 31, 2026 |  | $ | 824 |
See Note 12 for assets and liabilities which are measured at fair value on a recurring basis by level within the fair value hierarchy.

X
- References No definition available. + Details
Name: | FEED_DisclosureWarrantLiabilityAbstract
Namespace Prefix: | FEED_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrant Liability Disclosure [Text Block] + References No definition available. + Details
Name: | FEED_WarrantLiabilityDisclosureTextBlock
Namespace Prefix: | FEED_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration